Zdrowie i gospodarka · 29/04/2022

FDA Releases Draft Guidance for Developing Drugs to Treat Crohn's Disease

The Food and Drug Administration (FDA) has released a draft guidance document for the pharmaceutical industry, outlining the agency's recommendations for developing drugs to treat Crohn's disease in adults. The guidance focuses on essential attributes of clinical trials, including trial population, design, and efficacy and safety considerations.